Therefore, understanding the mechanisms underlying proliferation induced by SH2B1 expression not only helps to understand NSCLC growth promotion, but also can provide a platform to develop a novel therapeutic option in NSCLC therapy. This evidence concerns the gene SH2B1 and non-small cell lung carcinoma.